Global Lidocaine Transdermal Patch Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Lidocaine Transdermal Patch Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
Lidocaine Transdermal Patch report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lidocaine Transdermal Patch market is projected to reach US$ 249.9 million in 2034, increasing from US$ 203.8 million in 2022, with the CAGR of 3.0% during the period of 2024 to 2034. Demand from Online Pharmacies and Hospital Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lidocaine Transdermal Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lidocaine Transdermal Patch key manufacturers include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. Teikoku, Teva Pharmaceutical, Sorrento Therapeutics are top 3 players and held % sales share in total in 2022.
Lidocaine Transdermal Patch can be divided into Lidocare 5% Transdermal Patch, Lidocare 1.80% Transdermal Patch and Lidocare 4% Transdermal Patch,, etc. Lidocare 5% Transdermal Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Lidocaine Transdermal Patch is widely used in various fields, such as Online Pharmacies, Hospital Pharmacies, Clinic and Monomer Pharmacies, etc. Online Pharmacies provides greatest supports to the Lidocaine Transdermal Patch industry development. In 2022, global % sales of Lidocaine Transdermal Patch went into Online Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lidocaine Transdermal Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
Segment by Type
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Lidocaine Transdermal Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lidocaine Transdermal Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lidocaine Transdermal Patch industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Lidocaine Transdermal Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lidocaine Transdermal Patch introduction, etc. Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lidocaine Transdermal Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Lidocaine Transdermal Patch report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lidocaine Transdermal Patch market is projected to reach US$ 249.9 million in 2034, increasing from US$ 203.8 million in 2022, with the CAGR of 3.0% during the period of 2024 to 2034. Demand from Online Pharmacies and Hospital Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lidocaine Transdermal Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lidocaine Transdermal Patch key manufacturers include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. Teikoku, Teva Pharmaceutical, Sorrento Therapeutics are top 3 players and held % sales share in total in 2022.
Lidocaine Transdermal Patch can be divided into Lidocare 5% Transdermal Patch, Lidocare 1.80% Transdermal Patch and Lidocare 4% Transdermal Patch,, etc. Lidocare 5% Transdermal Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Lidocaine Transdermal Patch is widely used in various fields, such as Online Pharmacies, Hospital Pharmacies, Clinic and Monomer Pharmacies, etc. Online Pharmacies provides greatest supports to the Lidocaine Transdermal Patch industry development. In 2022, global % sales of Lidocaine Transdermal Patch went into Online Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lidocaine Transdermal Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
Segment by Type
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Segment by Application
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Lidocaine Transdermal Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lidocaine Transdermal Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lidocaine Transdermal Patch industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Lidocaine Transdermal Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lidocaine Transdermal Patch introduction, etc. Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lidocaine Transdermal Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices